Katie A Greenzang1,2,3,4,5, Colleen A Kelly4,5,6, Hasan Al-Sayegh1,3, Clement Ma7,8, Jennifer W Mack1,2,3,4,5. 1. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. 2. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts. 3. Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts. 4. Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts. 5. Harvard Medical School, Harvard University, Boston, Massachusetts. 6. Boston University School of Medicine, and Boston Medical Center, Boston, Massachusetts. 7. Centre for Addiction and Mental Health, Toronto, Canada. 8. Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Abstract
BACKGROUND: Many childhood cancersurvivors experience at least one late effect of treatment, and both late effects and persistent cancer-related worry can negatively impact quality of life in survivorship. Little is known about the prevalence or impact of parental worry about late effects early in treatment. This study evaluated parental perceived likelihood, impact, and worry about late effects of childhood cancer. PROCEDURE: We surveyed 96 parents of pediatric cancer patients at Dana-Farber/Boston Children's Cancer and Blood Disorders Center within a year of diagnosis. Parents were asked about their experiences with late effects communication, general worry about late effects, and specific late effect worries. RESULTS: Most (96%) parents valued information about late effects, and 93% considered late effects in their treatment decision-making. Yet, 24% could not recall receiving any information about late effects, and only 51% felt well prepared for potential late effects. Though only 20% of parents considered their child at high risk of experiencing late effects, 61% were extremely/very worried about late effects. Those who felt their child was at high risk of experiencing late effects were more likely to worry (OR = 4.7, P = 0.02). CONCLUSIONS: Many parents feel inadequately informed about late effects of cancer treatment, and only one-fifth of parents consider late effects to be likely for their child. However, a majority of parents worry about late effects, including ones they think their child is unlikely to experience. Although some worry is anticipated, disproportionate worry may be mitigated by addressing both educational shortfalls and emotional concerns.
BACKGROUND: Many childhood cancersurvivors experience at least one late effect of treatment, and both late effects and persistent cancer-related worry can negatively impact quality of life in survivorship. Little is known about the prevalence or impact of parental worry about late effects early in treatment. This study evaluated parental perceived likelihood, impact, and worry about late effects of childhood cancer. PROCEDURE: We surveyed 96 parents of pediatric cancer patients at Dana-Farber/Boston Children's Cancer and Blood Disorders Center within a year of diagnosis. Parents were asked about their experiences with late effects communication, general worry about late effects, and specific late effect worries. RESULTS: Most (96%) parents valued information about late effects, and 93% considered late effects in their treatment decision-making. Yet, 24% could not recall receiving any information about late effects, and only 51% felt well prepared for potential late effects. Though only 20% of parents considered their child at high risk of experiencing late effects, 61% were extremely/very worried about late effects. Those who felt their child was at high risk of experiencing late effects were more likely to worry (OR = 4.7, P = 0.02). CONCLUSIONS: Many parents feel inadequately informed about late effects of cancer treatment, and only one-fifth of parents consider late effects to be likely for their child. However, a majority of parents worry about late effects, including ones they think their child is unlikely to experience. Although some worry is anticipated, disproportionate worry may be mitigated by addressing both educational shortfalls and emotional concerns.
Authors: Robert B Lindell; Shannon J Koh; JoAnn M Alvarez; Tatsuki Koyama; Adam J Esbenshade; Jill H Simmons; Debra L Friedman Journal: Pediatr Blood Cancer Date: 2015-04-20 Impact factor: 3.167
Authors: Abby R Rosenberg; Miranda C Bradford; Elizabeth McCauley; J Randall Curtis; Joanne Wolfe; K Scott Baker; Joyce P Yi-Frazier Journal: Cancer Date: 2018-09-19 Impact factor: 6.860
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: Lisa Ljungman; Martin Cernvall; Helena Grönqvist; Brjánn Ljótsson; Gustaf Ljungman; Louise von Essen Journal: PLoS One Date: 2014-07-24 Impact factor: 3.240
Authors: Abby R Rosenberg; Miranda C Bradford; Courtney C Junkins; Mallory Taylor; Chuan Zhou; Nicole Sherr; Erin Kross; J Randall Curtis; Joyce P Yi-Frazier Journal: JAMA Netw Open Date: 2019-09-04